A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosus.
Tanaka Y, Yamamoto K, Takeuchi T, Nishimoto N, Miyasaka N, Sumida T, Shima Y, Takada K, Matsumoto I, Saito K, Koike T.
Tanaka Y, et al. Among authors: takeuchi t.
Mod Rheumatol. 2007;17(3):191-7. doi: 10.1007/s10165-007-0565-z. Epub 2007 Jun 20.
Mod Rheumatol. 2007.
PMID: 17564773
Clinical Trial.